Potential drug treats fatty liver disease in animal models, brings hope for first human treatment

A potential drug successfully treats the severe form of nonalcoholic fatty liver disease in non-human primates -- bringing scientists one step closer to the first human treatment for the condition that is rapidly increasing around the world, a study suggests. Nonalcoholic steatohepatitis (NASH) causes scarring and inflammation in the liver and is estimated to affect up to 6.5% of the global population.

from Top Health News -- ScienceDaily https://ift.tt/zTBc7K9